Testing Done Simple SARS CoV-2 Antigen Test
Diagnostic TestCollections of specimens from subjects presenting with Covid-19 like symptoms or known/suspected exposure to SARS CoV-2 via nasal swabs administered by trained medical personnel.
NCT Number: NCT05610449
This study will measure the sensitivity and specificity of the Testing Done Simple severe acute respiratory syndrome (SARS) CoV-2 antigen test in subjects with suspected Covid-19 that present throughout several urgent care clinics. The antigen test performance will be compared to a real-time polymerase chain reaction (RT-PCR) test.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Nao Medical Urgent Care-Astoria, Queens, New York, United States
The Testing Done Simple antigen test is a lateral flow immunoassay that detects the presence of the SARS CoV-2 nucleoprotein and is primarily intended for use in an at home setting. The antigen test will be compared to a traditional RT-PCR tested nasal swab specimens. The purpose of study is to measure the performance of the Testing Done Simple test via sensitivity and specificity when compared to the gold-standard RT-PCR test. The test will be administered in symptomatic and asymptomatic subjects and participants will report the days that has passed since their symptom onset. The RT-PCR test will be performed prior to the Testing Done Simple test.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Collections of specimens from subjects presenting with Covid-19 like symptoms or known/suspected exposure to SARS CoV-2 via nasal swabs administered by trained medical personnel.
Time frame: 15 minutes
Sensitivity (True Positive Rate) of Testing Done Simple Antigen Test compared to RT-PCR
Time frame: 15 minutes
Specificity (True Negative Rate) of Testing Done Simple Antigen Test compared to RT-PCR
Time frame: 15 minutes
Sensitivity of Testing Done Simple Antigen Test according to the days of symptom onset in symptomatic subjects
Testing Done Simple
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05004181
COVID-19, Coronaviridae Infections
Long Beach, California, United States
View Trial DetailsNCT05105789
COVID-19, Coronaviridae Infections
Madison, Wisconsin, United States
View Trial DetailsNCT05228639
COVID-19, Coronaviridae Infections
Manhiça, Mozambique
View Trial DetailsNCT04378452
Behavior, COVID-19
Badalona, Catalonia, Spain
View Trial Details